A Human Cell-based Assay to Assess the Induction of Vasculature Formation for Non-genotoxic Carcinogenicity Testing Purposes: A Pilot Study

Altern Lab Anim. 2023 May;51(3):188-203. doi: 10.1177/02611929231171165. Epub 2023 Apr 26.

Abstract

The induction of vasculature formation is proposed to be a significant mechanism behind the non-genotoxic carcinogenicity of a chemical. The vasculature formation model used in this study is based on the coculture of human primary HUVECs and hASCs. This model was used to develop an assay to assess the induction of vasculature formation. Three assay protocols, based on different conditions, were developed and compared in order to identify the optimal conditions required. Some serum supplements and growth factors were observed to be essential for initiating vasculature formation. Of the studied putative positive reference chemicals, aspartame, sodium nitrite, bisphenol A and nicotine treatment led to a clear induction of vasculature formation, but arsenic and cadmium treatment only led to a slight increase. This human cell-based assay has the potential to be used as one test within a next generation testing battery, to assess the non-genotoxic carcinogenicity of a chemical through the mechanism of vasculature formation induction.

Keywords: angiogenesis; in vitro model; non-genotoxic carcinogenicity; vascular model; vascular toxicity; vasculature formation; vasculogenesis.

MeSH terms

  • Carcinogenicity Tests / methods
  • Carcinogens*
  • Humans
  • Pilot Projects

Substances

  • Carcinogens